Cargando…
ACE2 and COVID-19: using antihypertensive medications and pharmacogenetic considerations
COVID-19 utilizes the ACE2 pathway as a means of infection. Early data on COVID-19 suggest heterogeneity in the severity of symptoms during transmission and infection ranging from no symptoms to death. The source of this heterogeneity is likely multifaceted and may have a genetic component. Demograp...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Future Medicine Ltd
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373206/ https://www.ncbi.nlm.nih.gov/pubmed/32501190 http://dx.doi.org/10.2217/pgs-2020-0048 |